单细胞和批量转录组分析揭示了瘤细胞异质性和皮膜黑色素瘤的潜在分子程序
Ke Li1,2, Jingzhe Huang1,2, Ying Tan1,2
1State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
Journal of translational medicine
|November 13, 2024
概括
这项研究揭示了皮膜黑色素瘤 (UM),一种罕见的眼睛癌症显著的瘤内异质性. 根据基因表达识别不同的亚型可以改善患者分层和治疗策略.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 卵巢黑色素瘤 (UM) 是一种具有高转移风险的侵袭性眼癌.
- 在UM瘤中,分子特征和细胞异质性尚未完全理解.
研究的目的:
- 在单细胞水平上表征毛膜黑色素瘤的瘤内异质性.
- 根据细胞异质性识别UM的分子亚型.
- 开发一种基因特征,用于UM患者的预后分层.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 对来自17个UM瘤的37660个恶性细胞进行了测序.
- 协商一致的非负因子化确定了驱动异质性的转录程序.
- 使用机器学习开发了一种9基因的签名,用于患者分层.
主要成果:
- ScRNA-seq揭示了各种恶性细胞亚群和UM瘤内部和之间的转录变异性.
- 恶性细胞异质性与基因组,免疫学和临床特征相关.
- 确定了两个不同的瘤内亚型 (ITMHlo和ITMHhi),在预后和免疫微环境上有所不同.
结论:
- 这项研究阐明了脑膜黑色素瘤的瘤内异质性.
- 鉴定到的亚型和基因特征为改善UM患者分层提供了潜力.
更多相关视频
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018
6.6K
05:58Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
Published on: August 16, 2024
2.7K
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...